AI Verdict
GILD has stronger fundamentals based on our AI analysis.
GILD vs HCA Fundamental Comparison
| Metric | GILD | HCA |
|---|---|---|
| Revenue | $7.0B | $19.1B |
| Net Income | $2.0B | $1.6B |
| Net Margin | 29.0% | 8.5% |
| ROE | 8.6% | N/A |
| ROA | 3.6% | 2.6% |
| Current Ratio | 1.97x | 0.83x |
| Debt/Equity | 0.94x | N/A |
| EPS | $1.61 | $7.15 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GILD vs HCA: Frequently Asked Questions
Is GILD or HCA the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GILD has stronger fundamentals. GILD is graded A (78% confidence) while HCA is graded A (76% confidence). This is not investment advice.
How does GILD compare to HCA fundamentally?
GILEAD SCIENCES, INC. has ROE of 8.6% vs HCA Healthcare, Inc.'s N/A. Net margins are 29.0% vs 8.5% respectively.
Which stock pays higher dividends, GILD or HCA?
GILD has a dividend yield of N/A or no dividend while HCA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GILD or HCA for long term?
For long-term investing, consider that GILD has a A grade with 78% confidence, while HCA has a A grade with 76% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GILD vs HCA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GILD vs HCA, the AI consensus favors GILD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.